Gasporox: Orders up, but earnings linger for 2024 - Redeye

Redeye states that net sales were slightly higher than expected, but OPEX was also higher. EBITDA was still in line. After a solid 2023, we believe 2024 will be a transitional year with continued net sales growth but higher OPEX. We estimate Gasporox’s order book to be SEK12.6m (35% of 2024e net sales). Redeye lowers its base case, but bull and bear cases remain unchanged.

Länk till analysen i sin helhet: https://www.redeye.se/research/980192/gasporox-2024-orders-up-but-earnings-linger?utm_source=finwire&utm_medium=RSS